Collaborating Authors

Nobel medicine laureate Tasuku Honjo visits longtime barber ahead of ceremony

The Japan Times

KYOTO – Nobel Prize-winning Japanese scientist Tasuku Honjo stopped in over the weekend at a Kyoto barbershop he has been visiting for over half a century as he prepares for his trip to Stockholm next week for the award ceremony. On Sunday, the 76-year-old, who won this year's Nobel Prize in physiology or medicine along with American James Allison for their studies on cancer therapy, was seen at the shop in Kyoto chatting with his 81-year-old longtime barber. "Hey, your hands are shaky. Haven't you ever thought of retiring?" the professor emeritus at Kyoto University asked barber Koichi Ueda, who works with his son at the Biriken barber shop near the university. "He was the kind of student who did not hesitate to speak up about his opinions," Ueda said about his impression of Honjo back when he first came to the shop Their discussions while Honjo was in the barber's chair ranged from the student uprisings of the 1970s to baseball.

Nobel laureate Tasuku Honjo calls for a better environment in Japan for life science research

The Japan Times

Nobel laureate and immunologist Tasuku Honjo on Tuesday called for a better environment in Japan for conducting research in the life sciences, saying more efforts are needed by both the private and public sectors in enabling researchers to come up with medical cures for illnesses such as cancer. The Kyoto University professor, who was awarded this year's Nobel Prize in medicine for his studies on cancer therapy that focus on controlling the immune system, told a meeting of ruling lawmakers at the Liberal Democratic Party headquarters in Tokyo about difficulties in the process that led to the development of the immunotherapeutic drug Opdivo. He spoke of his partnership with a Japanese pharmaceutical firm that didn't always work, his cooperation with a U.S. company that led to clinical trials for the drug and his recollection that the favorable results of the tests that came out in 2012 were not covered by the Japanese media. "Researchers around the world were surprised by the results because at the time people didn't think immunotherapy was effective in treating cancer," Honjo said. "Most of the patients who took part in the clinical trials were terminal cancer patients and the drug was effective for 20 to 30 percent of those patients. In addition, the effect continued even after administering of the medicine was stopped after half a year," he said.

Japanese professor Tasuku Honjo wins Nobel in medicine, together with U.S. scientist, for work on cancer therapy

The Japan Times

STOCKHOLM – Japanese scientist Tasuku Honjo was awarded on Monday this year's Nobel Prize in physiology or medicine, for his discovery of a protein that contributed to the development of an immunotherapeutic drug against cancer. Honjo, a 76-year-old professor at Kyoto University, won the prize with U.S. national James Allison, the Nobel Assembly at the Karolinska Institute said. Honjo opened a pathway for a new cancer treatment by discovering the PD-1 protein, which is responsible for suppressing immune response. "I'm very honored and pleased to receive the Nobel Prize in physiology or medicine," Honjo told a news conference following the announcement. His method of treating cancer -- by controlling the protein's function to suppress immunity -- led to the development of Nivolumab, a drug marketed as Opdivo and used against lung cancer and melanoma.

Nobel Prize winner Tasuku Honjo calls for better-funded and more imaginative pharma industry in Japan

The Japan Times

KYOTO – On the evening of Oct. 1, Dr. Tasuku Honjo was in his office at Kyoto University discussing a manuscript with two of his colleagues when a secretary came dashing in to announce there was a call from Sweden. Shortly afterward, details of that call would make news around the world: Honjo, 76, along with Dr. James Allison, 70, of the University of Texas MD Anderson Cancer Center, were jointly awarded the 2018 Nobel for Physiology or Medicine for their pioneering work in immunology -- work that has helped pave the way for a new generation of cancer treatment and drugs. In a recent interview in the same office where he took the Nobel Assembly's call, Honjo admitted his surprise -- it's not every day one is informed of a Nobel Prize win -- but he was also skeptical, for the same reasons. "The person who called me raised the issue (of prank calling), and so he asked me if I would like email confirmation during the call," Honjo said. "I said, 'Of course, yes.'"

The Nobel Prize in medicine goes to James P. Allison and Tasuku Honjo

Los Angeles Times

The Nobel Prize in medicine has been jointly awarded to James Allison of the University of Texas and Tasuku Honjo of Japan's Kyoto University for discovering a form of cancer therapy. The $1.01 million prize was announced Monday by the Nobel Assembly of Sweden's Karolinska Institute.